NASDAQ:RYTM News 11 December 2025

Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus

Rhythm Pharmaceuticals shares dropped 4.2% to $107.85 in early afternoon trading Tuesday as biotech stocks broadly declined. Investors are awaiting an FDA decision on expanding Imcivree’s label, now expected by March 20, 2026. Board member Camille L. Bedrosian resigned effective immediately, according to an SEC filing. Major biotech ETFs fell over 1% while the broader market was flat.

30 December 2025

NASDAQ:RYTM·Pharmaceuticals·Stock Market

Rhythm Pharmaceuticals (RYTM) Hits Record High on Rare-Disease Breakthrough: Latest News, Stock Forecast and Analyst Outlook

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stock is on a tear. On 11 December 2025, shares surged to a new all‑time high after the company reported encouraging mid‑stage data in Prader‑Willi syndrome (PWS) and investors refocused on a growing obesity franchise built around its melanocortin‑4 receptor (MC4R) agonist, IMCIVREE (setmelanotide).Investing.com+1 As of Thursday morning, RYTM was trading around $121 per share, up more than 15% on the day according to real‑time data from MarketBeat, and roughly 80–90% higher year‑to‑date.MarketBeat+2Investing.com+2 For a mid‑cap biotech that is still loss‑making, that kind of move demands a closer look at what changed, what analysts expect

11 December 2025

NASDAQ:RYTM·Stock Market

Shell stock: What to watch after PwC audit switch and Kazakhstan warning as buybacks roll on

7 February 2026

Shell shares closed up 0.18% at 2,774.5 pence in London on Friday. The company named PwC as auditor from 2027, replacing EY after compliance issues. CEO Wael Sawan said Shell will pause new investments in Kazakhstan due to legal disputes. Shell also disclosed further share buybacks this week.

Reliance Industries share price in focus after Australia consumer deal ahead of Monday trade

7 February 2026

Reliance Industries shares closed up 0.5% at 1,450.80 rupees on Friday after its consumer unit bought a majority stake in Australia’s Goodness Group Global. The deal’s financial terms were not disclosed. Reliance remains about 10% below its 52-week high, with trading volume at half the 50-day average. Indian markets reopen Monday.

China Mobile Class A (600941) price: BeiDou satellite SMS roll-out in focus before Shanghai reopens

7 February 2026

China Mobile’s Shanghai-listed shares closed at 95.11 yuan, down 0.26% Friday, as the Shanghai Composite Index slipped 0.25%. The company and rivals launched BeiDou satellite texting for use without ground networks. A new tax rule raises VAT on telecom services to 9% from 6% starting Jan. 1, 2026, which China Mobile said will impact revenue and profit.

Bank of China A Shares Slip Into Monday After Anti-Graft Headline — What to Watch Next

7 February 2026

Bank of China A shares closed at 5.35 yuan in Shanghai Friday, down 0.93%. State media reported former vice president Lin Jingzhen was expelled from the Communist Party for “serious violations of discipline and law”. No details of the alleged misconduct were released. The stock is down about 6.6% year-to-date.

NASDAQ:RYTM News 11 December 2025 - 30 December 2025

Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus

Rhythm Pharmaceuticals (RYTM) Hits Record High on Rare-Disease Breakthrough: Latest News, Stock Forecast and Analyst Outlook

Stock Market Today

Shell stock: What to watch after PwC audit switch and Kazakhstan warning as buybacks roll on

Reliance Industries share price in focus after Australia consumer deal ahead of Monday trade

China Mobile Class A (600941) price: BeiDou satellite SMS roll-out in focus before Shanghai reopens

Bank of China A Shares Slip Into Monday After Anti-Graft Headline — What to Watch Next